Cross-sectional study of the effectiveness and safety of proton beam therapy for liver metastatic 3 or less lesions in colorectal cancer patients without extrahepatic tumor
Not Applicable
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-UMIN000041792
- Lead Sponsor
- Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University
- Brief Summary
The 1-, 2-, and 3-year LC rates were 76.9%, 54.9%, and 54.9%, respectively. The median LC time was 47.3 months. The 1-, 2-, and 3-year OS rates were 90.1%, 67.8%, and 61.6%, respectively. The median OS time was 46.5 months. The 1-, 2-, and 3-year PFS rates were 46.3%, 22.3%, and 16.7%, respectively. The median PFS time was 9.7 months
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients without follow-up data
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Local control rates 2) Overall survival rates 3) Progression-free survival rates 4) Adverse events
- Secondary Outcome Measures
Name Time Method